ArentFox Schiff LLP

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases1167

Challenger50%

Patent Owner50%

NPE50%

arent-fox

arentfox.com

Practice Areas

BiotechMech Eng, ManufTransport., E-Comm.

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation 1:21-MD-03017 ( D. DE )	REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [297] . (nms) (Entered: 09/16/2024)
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024) BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024)
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024) BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024)
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	MOTION for Partial Summary Judgment by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: # [1] Declaration of Charles H. Chevalier, # [2] Exhibit A, # [3] Exhibit B, # [4] Text of Proposed Order, # [5] Certificate of Service)(CHEVALIER, CHARLES) (Entered: 09/13/2024)
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	MOTION for Partial Summary Judgment by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: # [1] Declaration of Charles H. Chevalier, # [2] Exhibit A, # [3] Exhibit B, # [4] Text of Proposed Order, # [5] Certificate of Service)(CHEVALIER, CHARLES) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:21-CV-00870 ( D. DE )	Pro Hac Vice Attorney Seth W. Lloyd, Deanne E. Maynard for Novartis Pharmaceuticals Corporation, added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:21-CV-00870 ( D. DE )	SO ORDERED, re [159] Motion for Pro Hac Vice Appearance of Attorney Deanne E. Maynard and Seth W. Lloyd filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. Ordered by Judge Jennifer L. Hall on 9/13/2024. (ceg) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:21-CV-00870 ( D. DE )	Pro Hac Vice Attorney Seth W. Lloyd, Deanne E. Maynard for Novartis Pharmaceuticals Corporation, added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 09/13/2024)
09/13/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:21-CV-00870 ( D. DE )	SO ORDERED, re [159] Motion for Pro Hac Vice Appearance of Attorney Deanne E. Maynard and Seth W. Lloyd filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. Ordered by Judge Jennifer L. Hall on 9/13/2024. (ceg) (Entered: 09/13/2024)
09/12/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	[SEALED] OPENING BRIEF in Support re [94] MOTION in Limine Regarding Certain Opinions of Dr. Pamela Smith filed by MSN Laboratories Private Ltd..Answering Brief/Response due date per Local Rules is 9/26/2024. (Attachments: # [1] Exhibit Exhibit A to Declaration, # [2] Exhibit Exhibit B to Declaration, # [3] Exhibit Exhibit C to Declaration)(Green, James) (Entered: 09/12/2024)